Max Robotics — Global Service Robot Directory + US Certification

About

Muhannad Aljoulani is a pioneering urologic surgeon and researcher at the forefront of single-port (SP) robotic-assisted surgery. His primary research focuses on optimizing minimally invasive techniques for prostate cancer and benign prostatic hyperplasia, with a particular emphasis on the Da Vinci SP platform. Aljoulani’s major contributions include defining the learning curve for single-port robotic-assisted radical prostatectomy (SP-RARP) through rigorous CUSUM-based analysis, demonstrating that the SP approach is not more difficult to master than traditional multi-port surgery. He has also led systematic reviews and meta-analyses establishing the current status of SP robotic-assisted reconstructive urology. His work on same-day discharge after SP simple prostatectomy introduced the concept of a “trifecta” for benign disease, while his comparative studies in elderly patients show that SP-RARP is safe and effective regardless of age. With over 28 citations across his 2025 publications, Aljoulani’s research is rapidly shaping clinical practice. His multi-institutional cohort analyses and focus on optimizing outcomes for seniors highlight his commitment to evidence-based surgical innovation that expands access to advanced care.